Off-label Use of Antipsychotics in the Community Pharmacy: The Sex Differences

Pharmacopsychiatry

Volumn 36, Issue 5, 2003, Pages 187-191

  Rijcken, C A W ^a   Boelema, G J ^b   Slooff, C J ^c   Beuger, P J ^b   Tanja, T A ^b   De Jong Van Den Berg, L T W ^a,d  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Health Care Centre Beyum Groningen   (Netherlands)

^c Mental Health Centre Drenthe   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Antipsychotic; Diagnosis; Dose; Off label; Sex

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGITATION; ARTICLE; COMMUNITY; COMORBIDITY; DRUG INDICATION; DRUG USE; FEMALE; GENERAL PRACTITIONER; HUMAN; LOCOMOTION; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DISEASE; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SEX DIFFERENCE;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACIES; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 0242320559     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-43048     Document Type: Article

References (18)

1. Andia AM, Zisook S, Heaton RK, Hesselink J, Jernigan T, Kuck J et al. Gender differences in schizophrenia. J Nerv Ment Dis 1995: 183: 22-28
2. Dutch Drug Information Center WINAP. Informatorium Medicamentorum, 1998
3. Dutch Drug Information Center WINAP. Informatorium Medicamentorum, 2000
4. Feifel D. Rationale and guidelines for the inpatient treatment of acute psychosis. J Clin Psychiatry 2000; 61: 27-32
5. Fourrier A, Gasquet I, Allicar MP, Bouhassira M, Lepine JP, Begaud B. Patterns of neuroleptic drug prescription: a national cross-sectional survey of a random sample of french psychiatrists. Br J Clin Pharm 2000; 49(1): 80-86
6. Glick ID, Murray SR, Vasudevan P, Marder SR, Hu RJ. Treatment with atypical antipsychotics: new indications and new populations. J Psych Res 2001; 35: 187-191
7. Goodnick PJ and Barrios CA. Use of olanzapine in non-psychotic psychiatric disorders. Exp Opin Pharmacother 2001; 2(4): 667-680
8. Linden M, Thiels C. Epidemiology of prescriptions for neuroleptic drugs: tranquilizers rather than antipsychotics. Pharmacopsychiatry 2001; 34: 150-154
9. McElroy SL, Keck PE, Strakowski SM. Mania, psychosis and antipsychotics. J Clin Psychiatry 1996; 57 (suppl 3): 4-26
10. McEvoy JP, Hogarty GE, Steingard S. Optimal dose of neuroleptic in acute schizophrenia. Arch Gen Psychiatry 1991; 48: 739-745
11. Owens C. Newer versus older antipsychotics. Drugs 1996; 51: 896-930
12. Pinals DA, Malhotra AK, Missar CD, Pickar D, Breier A. Lack of gender differences in neuroleptic response in patients with schizophrenia. Schizophr Res 1996; 22: 215-222
13. Rosenheck R, Leslie D, Sernyak M. From clinical trial to real-world practice: use of atypical antipsychotic medication nationally in the department of veterans affairs. Med Care 2001; 34: 302-308
14. Tamminga CA. Gender and schizophrenia. J Clin Psychiatry 1997; 58 (suppl 15): 3-37
15. Targum SD, Abbott JL. Psychoses in the elderly: A spectrum of disorders. J Clin Psychiatry 1999; 60 (Suppl 8): 4-10
16. Weiss E, Hummer M, Koller D, Ulmer H, Fleischhacker W. Off-label use of antipsychotic drugs. J Clin Psychopharmacol 2000; 20: 695-698
17. WHO. WHO collaborating centre for drug statistics methodology. ATC index with DDDs 2001. WHO: Oslo, 2001
18. Yonkers KA, Kando JC, Cole JO, Blumenthal S. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 1992; 149: 587-593